{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:50:50Z","timestamp":1778539850770,"version":"3.51.4"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T00:00:00Z","timestamp":1645315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T00:00:00Z","timestamp":1645315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Numerous pharmaceutical drugs have been repurposed for use as treatments for COVID-19 disease. These drugs have not consistently demonstrated high efficacy in preventing or treating this serious condition and all have side effects to differing degrees. We encourage the continued consideration of the use of the antioxidant and anti-inflammatory agent, melatonin, as a countermeasure to a SARS-CoV-2 infection. More than 140 scientific publications have identified melatonin as a likely useful agent to treat this disease. Moreover, the publications cited provide the rationale for the use of melatonin as a prophylactic agent against this condition. Melatonin has pan-antiviral effects and it diminishes the severity of viral infections and reduces the death of animals infected with numerous different viruses, including three different coronaviruses. Network analyses, which compared drugs used to treat SARS-CoV-2 in humans, also predicted that melatonin would be the most effective agent for preventing\/treating COVID-19. Finally, when seriously infected COVID-19 patients were treated with melatonin, either alone or in combination with other medications, these treatments reduced the severity of infection, lowered the death rate, and shortened the duration of hospitalization. Melatonin\u2019s ability to arrest SARS-CoV-2 infections may reduce health care exhaustion by limiting the need for hospitalization. Importantly, melatonin has a high safety profile over a wide range of doses and lacks significant toxicity. Some molecular processes by which melatonin resists a SARS-CoV-2 infection are summarized. The authors believe that all available, potentially beneficial drugs, including melatonin, that lack toxicity should be used in pandemics such as that caused by SARS-CoV-2.<\/jats:p>","DOI":"10.1007\/s00018-021-04102-3","type":"journal-article","created":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T19:02:23Z","timestamp":1645383743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection"],"prefix":"10.1007","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6763-4225","authenticated-orcid":false,"given":"Russel J.","family":"Reiter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramaswamy","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fedor","family":"Simko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Dominguez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Tesarik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard L.","family":"Neel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej T.","family":"Slominski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Kleszczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verna M.","family":"Martin-Gimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Manucha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel P.","family":"Cardinali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,20]]},"reference":[{"issue":"3","key":"4102_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.32794\/mr11250064","volume":"3","author":"DP Cardinali","year":"2020","unstructured":"Cardinali DP (2020) High doses of melatonin as a potential therapeutic tool for the neurologic sequels of covid-19 infection. Melatonin Res 3(3):311\u2013317. https:\/\/doi.org\/10.32794\/mr11250064","journal-title":"Melatonin Res"},{"key":"4102_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/diseases8040044","author":"DP Cardinali","year":"2020","unstructured":"Cardinali DP, Brown GM, Pandi-Perumal SR (2020) Can Melatonin Be a Potential \u201cSilver Bullet\u201d in Treating COVID-19 Patients? Diseases. https:\/\/doi.org\/10.3390\/diseases8040044","journal-title":"Diseases"},{"issue":"29","key":"4102_CR3","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.2217\/nnm-2020-0371","volume":"15","author":"VM Martin Gimenez","year":"2020","unstructured":"Martin Gimenez VM, Prado N, Diez E, Manucha W, Reiter RJ (2020) New proposal involving nanoformulated melatonin targeted to the mitochondria as a potential COVID-19 treatment. Nanomedicine (Lond) 15(29):2819\u20132821. https:\/\/doi.org\/10.2217\/nnm-2020-0371","journal-title":"Nanomedicine (Lond)"},{"key":"4102_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.15.20213546","author":"V Ramlall","year":"2020","unstructured":"Ramlall V, Zucker J, Tatonetti N (2020) Melatonin is significantly associated with survival of intubated COVID-19 patients. medRxiv. https:\/\/doi.org\/10.1101\/2020.10.15.20213546","journal-title":"medRxiv"},{"issue":"4","key":"4102_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.32794\/mr11250077","volume":"3","author":"J Tesarik","year":"2020","unstructured":"Tesarik J (2020) Melatonin attenuates growth factor receptor signaling required for SARS-CoV-2 replication. Melatonin Res 3(4):534\u2013537. https:\/\/doi.org\/10.32794\/mr11250077","journal-title":"Melatonin Res"},{"issue":"3","key":"4102_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.32794\/mr11250062","volume":"3","author":"D-X Tan","year":"2020","unstructured":"Tan D-X, Hardeland R (2020) Estimated doses of melatonin for treating deadly virus infections: focus on COVID-19. Melatonin Res 3(3):276\u2013296. https:\/\/doi.org\/10.32794\/mr11250062","journal-title":"Melatonin Res"},{"key":"4102_CR7","doi-asserted-by":"publisher","first-page":"117583","DOI":"10.1016\/j.lfs.2020.117583","volume":"250","author":"R Zhang","year":"2020","unstructured":"Zhang R, Wang X, Ni L, Di X, Ma B, Niu S, Liu C, Reiter RJ (2020) COVID-19: Melatonin as a potential adjuvant treatment. Life Sci 250:117583. https:\/\/doi.org\/10.1016\/j.lfs.2020.117583","journal-title":"Life Sci"},{"key":"4102_CR8","doi-asserted-by":"publisher","first-page":"111546","DOI":"10.1016\/j.jinorgbio.2021.111546","volume":"223","author":"OG Camp","year":"2021","unstructured":"Camp OG, Bai D, Gonullu DC, Nayak N, Abu-Soud HM (2021) Melatonin interferes with COVID-19 at several distinct ROS-related steps. J Inorg Biochem 223:111546. https:\/\/doi.org\/10.1016\/j.jinorgbio.2021.111546","journal-title":"J Inorg Biochem"},{"issue":"8","key":"4102_CR9","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.eprac.2021.06.001","volume":"27","author":"KM Cross","year":"2021","unstructured":"Cross KM, Landis DM, Sehgal L, Payne JD (2021) Melatonin for the early treatment of COVID-19: a narrative review of current evidence and possible efficacy. Endocr Pract 27(8):850\u2013855. https:\/\/doi.org\/10.1016\/j.eprac.2021.06.001","journal-title":"Endocr Pract"},{"key":"4102_CR10","doi-asserted-by":"publisher","DOI":"10.1515\/znc-2021-0101","author":"H Esmaeili Gouvarchin Ghaleh","year":"2021","unstructured":"Esmaeili Gouvarchin Ghaleh H, Hosseini A, Aghamollaei H, Fasihi-Ramandi M, Alishiri G, Saeedi-Boroujeni A, Hassanpour K, Mahmoudian-Sani MR, Farnoosh G (2021) NLRP3 inflammasome activation and oxidative stress status in the mild and moderate SARS-CoV-2 infected patients: impact of melatonin as a medicinal supplement. Z Naturforsch C J Biosci. https:\/\/doi.org\/10.1515\/znc-2021-0101","journal-title":"Z Naturforsch C J Biosci"},{"issue":"11","key":"4102_CR11","doi-asserted-by":"publisher","first-page":"e3000970","DOI":"10.1371\/journal.pbio.3000970","volume":"18","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Hou Y, Shen J, Mehra R, Kallianpur A, Culver DA, Gack MU, Farha S, Zein J, Comhair S, Fiocchi C, Stappenbeck T, Chan T, Eng C, Jung JU, Jehi L, Erzurum S, Cheng F (2020) A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19. PLoS Biol 18(11):e3000970. https:\/\/doi.org\/10.1371\/journal.pbio.3000970","journal-title":"PLoS Biol"},{"key":"4102_CR12","doi-asserted-by":"publisher","unstructured":"Root-Bernstein R (2021) Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI\/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions. Int J Mol Sci https:\/\/doi.org\/10.3390\/ijms22042108","DOI":"10.3390\/ijms22042108"},{"key":"4102_CR13","doi-asserted-by":"publisher","first-page":"117902","DOI":"10.1016\/j.lfs.2020.117902","volume":"256","author":"F Simko","year":"2020","unstructured":"Simko F, Reiter RJ (2020) Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19? Life Sci 256:117902. https:\/\/doi.org\/10.1016\/j.lfs.2020.117902","journal-title":"Life Sci"},{"key":"4102_CR14","doi-asserted-by":"publisher","first-page":"112107","DOI":"10.1016\/j.biopha.2021.112107","volume":"143","author":"S Mouffak","year":"2021","unstructured":"Mouffak S, Shubbar Q, Saleh E, El-Awady R (2021) Recent advances in management of COVID-19: a review. Biomed Pharmacother 143:112107. https:\/\/doi.org\/10.1016\/j.biopha.2021.112107","journal-title":"Biomed Pharmacother"},{"key":"4102_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168623","author":"A Wichniak","year":"2021","unstructured":"Wichniak A, Kania A, Sieminski M, Cubala WJ (2021) Melatonin as a potential adjuvant treatment for COVID-19 beyond sleep disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22168623","journal-title":"Int J Mol Sci"},{"key":"4102_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10071152","author":"E Ramos","year":"2021","unstructured":"Ramos E, Lopez-Munoz F, Gil-Martin E, Egea J, Alvarez-Merz I, Painuli S, Semwal P, Martins N, Hernandez-Guijo JM, Romero A (2021) The coronavirus disease 2019 (COVID-19): key emphasis on melatonin safety and therapeutic efficacy. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox10071152","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"4102_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/rmv.1714","volume":"22","author":"JA Boga","year":"2012","unstructured":"Boga JA, Coto-Montes A, Rosales-Corral SA, Tan DX, Reiter RJ (2012) Beneficial actions of melatonin in the management of viral infections: a new use for this \u201cmolecular handyman\u201d? Rev Med Virol 22(5):323\u2013338. https:\/\/doi.org\/10.1002\/rmv.1714","journal-title":"Rev Med Virol"},{"key":"4102_CR18","doi-asserted-by":"publisher","first-page":"198108","DOI":"10.1016\/j.virusres.2020.198108","volume":"287","author":"K Bahrampour Juybari","year":"2020","unstructured":"Bahrampour Juybari K, Pourhanifeh MH, Hosseinzadeh A, Hemati K, Mehrzadi S (2020) Melatonin potentials against viral infections including COVID-19: Current evidence and new findings. Virus Res 287:198108. https:\/\/doi.org\/10.1016\/j.virusres.2020.198108","journal-title":"Virus Res"},{"key":"4102_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/life11080864","author":"CH Lien","year":"2021","unstructured":"Lien CH, Lee MD, Weng SL, Lin CH, Liu LY, Tai YL, Lei WT, Liu JM, Huang YN, Chi H, Chiu NC, Lin CY (2021) Repurposing colchicine in treating patients with COVID-19: a systematic review and meta-analysis. Life (Basel). https:\/\/doi.org\/10.3390\/life11080864","journal-title":"Life (Basel)"},{"key":"4102_CR20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00769-2021","author":"D Ward","year":"2021","unstructured":"Ward D, Gortz S, Ernst MT, Andersen NN, Kjaer SK, Hallas J, Christensen S, Christiansen CF, Israelsen SB, Benfield T, Pottegard A, Jess T (2021) The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.00769-2021","journal-title":"Eur Respir J"},{"key":"4102_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-021-00316-1","author":"NK Younis","year":"2021","unstructured":"Younis NK, Zareef RO, Fakhri G, Bitar F, Eid AH, Arabi M (2021) COVID-19: potential therapeutics for pediatric patients. Pharmacol Rep. https:\/\/doi.org\/10.1007\/s43440-021-00316-1","journal-title":"Pharmacol Rep"},{"issue":"1","key":"4102_CR22","doi-asserted-by":"publisher","first-page":"17810","DOI":"10.1038\/s41598-021-97160-3","volume":"11","author":"C Ambrus","year":"2021","unstructured":"Ambrus C, Bakos E, Sarkadi B, Ozvegy-Laczka C, Telbisz A (2021) Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics. Sci Rep 11(1):17810. https:\/\/doi.org\/10.1038\/s41598-021-97160-3","journal-title":"Sci Rep"},{"issue":"1080\/09205063","key":"4102_CR23","first-page":"1975020","volume":"10","author":"M Malani","year":"2021","unstructured":"Malani M, Salunke P, Kulkarni S, Jain GK, Sheikh A, Kesharwani P (2021) Nirmal J (2021) Repurposing pharmaceutical excipients as an antiviral agent against SARS-CoV-2. J Biomater Sci Polym Ed 10(1080\/09205063):1975020","journal-title":"J Biomater Sci Polym Ed"},{"key":"4102_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-021-16715-z","author":"V Tiwari","year":"2021","unstructured":"Tiwari V, Kumar M, Tiwari A, Sahoo BM, Singh S, Kumar S, Saharan R (2021) Current trends in diagnosis and treatment strategies of COVID-19 infection. Environ Sci Pollut Res Int. https:\/\/doi.org\/10.1007\/s11356-021-16715-z","journal-title":"Environ Sci Pollut Res Int"},{"key":"4102_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2021.100121","author":"K Srivastava","year":"2021","unstructured":"Srivastava K, Singh MK (2021) Drug repurposing in COVID-19: a review with past, present and future. Metabol Open. https:\/\/doi.org\/10.1016\/j.metop.2021.100121","journal-title":"Metabol Open"},{"key":"4102_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102941","author":"F Elrashdy","year":"2021","unstructured":"Elrashdy F, Tambuwala MM, Hassan SS, Adadi P, Seyran M, Abd El-Aziz TM, Rezaei N, Lal A, Aljabali AAA, Kandimalla R, Bazan NG, Azad GK, Sherchan SP, Choudhury PP, Serrano-Aroca A, Takayama K, Chauhan G, Pizzol D, Barh D, Panda PK, Mishra YK, Palu G, Lundstrom K, Redwan EM, Uversky VN (2021) Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmun Rev. https:\/\/doi.org\/10.1016\/j.autrev.2021.102941","journal-title":"Autoimmun Rev"},{"issue":"1","key":"4102_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12872-021-02183-3","volume":"21","author":"AA Hasnie","year":"2021","unstructured":"Hasnie AA, Hasnie UA, Patel N, Aziz MU, Xie M, Lloyd SG, Prabhu SD (2021) Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovasc Disord 21(1):375. https:\/\/doi.org\/10.1186\/s12872-021-02183-3","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"4102_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12968-021-00795-4","volume":"23","author":"YR Patel","year":"2021","unstructured":"Patel YR, Louis DW, Atalay M, Agarwal S, Shah NR (2021) Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. J Cardiovasc Magn Reson 23(1):101. https:\/\/doi.org\/10.1186\/s12968-021-00795-4","journal-title":"J Cardiovasc Magn Reson"},{"key":"4102_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.biochi.2021.08.011","volume":"191","author":"W Al-Zyoud","year":"2021","unstructured":"Al-Zyoud W, Haddad H (2021) Dynamics prediction of emerging notable spike protein mutations in SARS-CoV-2 implies a need for updated vaccines. Biochimie 191:91\u2013103. https:\/\/doi.org\/10.1016\/j.biochi.2021.08.011","journal-title":"Biochimie"},{"issue":"1","key":"4102_CR30","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1080\/22221751.2021.1942230","volume":"10","author":"A Baj","year":"2021","unstructured":"Baj A, Novazzi F, Genoni A, Ferrante FD, Taborelli S, Pini B, Partenope M, Valli M, Gasperina DD, Capuano R, Prestia M, Spezia PG, Azzi L, Focosi D, Maggi F (2021) Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution. Emerg Microbes Infect 10(1):1254\u20131256. https:\/\/doi.org\/10.1080\/22221751.2021.1942230","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"4102_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/187221412799015317","volume":"6","author":"V Srinivasan","year":"2012","unstructured":"Srinivasan V, Mohamed M, Kato H (2012) Melatonin in bacterial and viral infections with focus on sepsis: a review. Recent Pat Endocr Metab Immune Drug Discov 6(1):30\u201339. https:\/\/doi.org\/10.2174\/187221412799015317","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"4102_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/diseases9020030","author":"VM Martin Gimenez","year":"2021","unstructured":"Martin Gimenez VM, de Las HN, Ferder L, Lahera V, Reiter RJ, Manucha W (2021) Potential Effects of Melatonin and Micronutrients on Mitochondrial Dysfunction during a Cytokine Storm Typical of Oxidative\/Inflammatory Diseases. Diseases. https:\/\/doi.org\/10.3390\/diseases9020030","journal-title":"Diseases"},{"issue":"1","key":"4102_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.32794\/mr11250049","volume":"3","author":"E Peschechera","year":"2020","unstructured":"Peschechera E, Veronesi PA (2020) Injectable melatonin: an anti-cancer and anti-viral treatment option. Melatonin Res 3(1):77\u201380. https:\/\/doi.org\/10.32794\/mr11250049","journal-title":"Melatonin Res"},{"issue":"4","key":"4102_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/jpi.12186","volume":"57","author":"DX Tan","year":"2014","unstructured":"Tan DX, Korkmaz A, Reiter RJ, Manchester LC (2014) Ebola virus disease: potential use of melatonin as a treatment. J Pineal Res 57(4):381\u2013384. https:\/\/doi.org\/10.1111\/jpi.12186","journal-title":"J Pineal Res"},{"issue":"1","key":"4102_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.32794\/mr11250047","volume":"3","author":"RJ Reiter","year":"2020","unstructured":"Reiter RJ, Ma Q, Sharma R (2020) Treatment of ebola and other infectious diseases: melatonin \u201cgoes viral.\u201d Melatonin Res 3(1):43\u201357. https:\/\/doi.org\/10.32794\/mr11250047","journal-title":"Melatonin Res"},{"issue":"10","key":"4102_CR36","doi-asserted-by":"publisher","first-page":"e0240149","DOI":"10.1371\/journal.pone.0240149","volume":"15","author":"L Artigas","year":"2020","unstructured":"Artigas L, Coma M, Matos-Filipe P, Aguirre-Plans J, Farres J, Valls R, Fernandez-Fuentes N, de la Haba-Rodriguez J, Olvera A, Barbera J, Morales R, Oliva B, Mas JM (2020) In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm. PLoS ONE 15(10):e0240149. https:\/\/doi.org\/10.1371\/journal.pone.0240149","journal-title":"PLoS ONE"},{"issue":"14","key":"4102_CR37","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.7150\/ijms.48053","volume":"17","author":"EL Feitosa","year":"2020","unstructured":"Feitosa EL, Junior F, Nery Neto JAO, Matos LFL, Moura MHS, Rosales TO, De Freitas GBL (2020) COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor. Int J Med Sci 17(14):2133\u20132146. https:\/\/doi.org\/10.7150\/ijms.48053","journal-title":"Int J Med Sci"},{"key":"4102_CR38","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.csbj.2021.02.009","volume":"19","author":"AP Chavarria","year":"2021","unstructured":"Chavarria AP, Vazquez RRV, Cherit JGD, Bello HH, Suastegui HC, Moreno-Castaneda L, Alanis Estrada G, Hernandez F, Gonzalez-Marcos O, Saucedo-Orozco H, Manzano-Pech L, Marquez-Velasco R, Guarner-Lans V, Perez-Torres I, Soto ME (2021) Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19. Comput Struct Biotechnol J 19:1379\u20131390. https:\/\/doi.org\/10.1016\/j.csbj.2021.02.009","journal-title":"Comput Struct Biotechnol J"},{"issue":"2","key":"4102_CR39","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1600-079X.2007.00516.x","volume":"44","author":"OF Tekbas","year":"2008","unstructured":"Tekbas OF, Ogur R, Korkmaz A, Kilic A, Reiter RJ (2008) Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule. J Pineal Res 44(2):222\u2013226. https:\/\/doi.org\/10.1111\/j.1600-079X.2007.00516.x","journal-title":"J Pineal Res"},{"key":"4102_CR40","doi-asserted-by":"publisher","first-page":"683879","DOI":"10.3389\/fimmu.2021.683879","volume":"12","author":"F He","year":"2021","unstructured":"He F, Wu X, Zhang Q, Li Y, Ye Y, Li P, Chen S, Peng Y, Hardeland R, Xia Y (2021) Bacteriostatic potential of melatonin: therapeutic standing and mechanistic insights. Front Immunol 12:683879. https:\/\/doi.org\/10.3389\/fimmu.2021.683879","journal-title":"Front Immunol"},{"issue":"6","key":"4102_CR41","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1203\/00006450-200112000-00021","volume":"50","author":"E Gitto","year":"2001","unstructured":"Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, Cordaro S, Corona G, Trimarchi G, Barberi I (2001) Effects of melatonin treatment in septic newborns. Pediatr Res 50(6):756\u2013760. https:\/\/doi.org\/10.1203\/00006450-200112000-00021","journal-title":"Pediatr Res"},{"issue":"14","key":"4102_CR42","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1055\/s-0037-1604244","volume":"34","author":"G D'Angelo","year":"2017","unstructured":"D\u2019Angelo G, Marseglia L, Reiter RJ, Buonocore G, Gitto E (2017) Melatonin and neonatal sepsis: a promising antioxidant adjuvant agent. Am J Perinatol 34(14):1382\u20131388. https:\/\/doi.org\/10.1055\/s-0037-1604244","journal-title":"Am J Perinatol"},{"issue":"1","key":"4102_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13052-018-0528-3","volume":"44","author":"G D'Angelo","year":"2018","unstructured":"D\u2019Angelo G, Impellizzeri P, Marseglia L, Montalto AS, Russo T, Salamone I, Falsaperla R, Corsello G, Romeo C, Gitto E (2018) Current status of laboratory and imaging diagnosis of neonatal necrotizing enterocolitis. Ital J Pediatr 44(1):84. https:\/\/doi.org\/10.1186\/s13052-018-0528-3","journal-title":"Ital J Pediatr"},{"issue":"9","key":"4102_CR44","doi-asserted-by":"publisher","first-page":"e21783","DOI":"10.1096\/fj.202100651R","volume":"35","author":"G Li","year":"2021","unstructured":"Li G, Lv D, Yao Y, Wu H, Wang J, Deng S, Song Y, Guan S, Wang L, Ma W, Yang H, Yan L, Zhang J, Ji P, Zhang L, Lian Z, Liu G (2021) Overexpression of ASMT likely enhances the resistance of transgenic sheep to brucellosis by influencing immune-related signaling pathways and gut microbiota. FASEB J 35(9):e21783. https:\/\/doi.org\/10.1096\/fj.202100651R","journal-title":"FASEB J"},{"key":"4102_CR45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149236","author":"JM Snider","year":"2021","unstructured":"Snider JM, You JK, Wang X, Snider AJ, Hallmark B, Zec MM, Seeds MC, Sergeant S, Johnstone L, Wang Q, Sprissler R, Carr TF, Lutrick K, Parthasarathy S, Bime C, Zhang HH, Luberto C, Kew RR, Hannun YA, Guerra S, McCall CE, Yao G, Del Poeta M, Chilton FH (2021) Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI149236","journal-title":"J Clin Invest"},{"issue":"4","key":"4102_CR46","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.it.2020.02.003","volume":"41","author":"VP van Hensbergen","year":"2020","unstructured":"van Hensbergen VP, Wu Y, van Sorge NM, Touqui L (2020) Type IIA Secreted Phospholipase A2 in Host Defense against Bacterial Infections. Trends Immunol 41(4):313\u2013326. https:\/\/doi.org\/10.1016\/j.it.2020.02.003","journal-title":"Trends Immunol"},{"issue":"1","key":"4102_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF02849996","volume":"24","author":"T Yavuz","year":"2007","unstructured":"Yavuz T, Kaya D, Behcet M, Ozturk E, Yavuz O (2007) Effects of melatonin on Candida sepsis in an experimental rat model. Adv Ther 24(1):91\u2013100. https:\/\/doi.org\/10.1007\/BF02849996","journal-title":"Adv Ther"},{"issue":"3","key":"4102_CR48","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.burns.2016.09.023","volume":"43","author":"CA Prauchner","year":"2017","unstructured":"Prauchner CA (2017) Oxidative stress in sepsis: pathophysiological implications justifying antioxidant co-therapy. Burns 43(3):471\u2013485. https:\/\/doi.org\/10.1016\/j.burns.2016.09.023","journal-title":"Burns"},{"issue":"2","key":"4102_CR49","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.bja.2017.12.010","volume":"120","author":"V Natesan","year":"2018","unstructured":"Natesan V (2018) Adrenergic blockade inhibits bacterial quorum sensing and reverses Warburg effect in septic shock. Br J Anaesth 120(2):412\u2013413. https:\/\/doi.org\/10.1016\/j.bja.2017.12.010","journal-title":"Br J Anaesth"},{"issue":"7779","key":"4102_CR50","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, Ding J, Czyz D, Hu R, Ye Z, He M, Zheng YG, Shuman HA, Dai L, Ren B, Roeder RG, Becker L, Zhao Y (2019) Metabolic regulation of gene expression by histone lactylation. Nature 574(7779):575\u2013580. https:\/\/doi.org\/10.1038\/s41586-019-1678-1","journal-title":"Nature"},{"issue":"1","key":"4102_CR51","doi-asserted-by":"publisher","first-page":"10793","DOI":"10.1038\/s41598-021-90192-9","volume":"11","author":"TV de Jong","year":"2021","unstructured":"de Jong TV, Guryev V, Moshkin YM (2021) Estimates of gene ensemble noise highlight critical pathways and predict disease severity in H1N1, COVID-19 and mortality in sepsis patients. Sci Rep 11(1):10793. https:\/\/doi.org\/10.1038\/s41598-021-90192-9","journal-title":"Sci Rep"},{"key":"4102_CR52","doi-asserted-by":"publisher","DOI":"10.1080\/08830185.2021.1974856","author":"Y Luo","year":"2021","unstructured":"Luo Y, Li L, Chen X, Gou H, Yan K, Xu Y (2021) Effects of lactate in immunosuppression and inflammation: progress and prospects. Int Rev Immunol. https:\/\/doi.org\/10.1080\/08830185.2021.1974856","journal-title":"Int Rev Immunol"},{"issue":"2","key":"4102_CR53","doi-asserted-by":"publisher","first-page":"e12547","DOI":"10.1111\/jpi.12547","volume":"66","author":"Y Xia","year":"2019","unstructured":"Xia Y, Chen S, Zeng S, Zhao Y, Zhu C, Deng B, Zhu G, Yin Y, Wang W, Hardeland R, Ren W (2019) Melatonin in macrophage biology: current understanding and future perspectives. J Pineal Res 66(2):e12547. https:\/\/doi.org\/10.1111\/jpi.12547","journal-title":"J Pineal Res"},{"key":"4102_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030657","author":"T Schmoch","year":"2017","unstructured":"Schmoch T, Uhle F, Siegler BH, Fleming T, Morgenstern J, Nawroth PP, Weigand MA, Brenner T (2017) The glyoxalase system and methylglyoxal-derived carbonyl stress in sepsis: glycotoxic aspects of sepsis pathophysiology. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18030657","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4102_CR55","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41392-021-00726-w","volume":"6","author":"M Tian","year":"2021","unstructured":"Tian M, Liu W, Li X, Zhao P, Shereen MA, Zhu C, Huang S, Liu S, Yu X, Yue M, Pan P, Wang W, Li Y, Chen X, Wu K, Luo Z, Zhang Q, Wu J (2021) HIF-1alpha promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal Transduct Target Ther 6(1):308. https:\/\/doi.org\/10.1038\/s41392-021-00726-w","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"4102_CR56","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20(6):355\u2013362. https:\/\/doi.org\/10.1038\/s41577-020-0331-4","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"4102_CR57","doi-asserted-by":"publisher","first-page":"105","DOI":"10.32794\/mr11250033","volume":"2","author":"RJ Reiter","year":"2019","unstructured":"Reiter RJ, Sharma R, Ma Q, Rosales-Corral S, Acuna-Castroviejo D, Escames G (2019) Inhibition of mitochondrial pyruvate dehydrogenase kinase: a proposed mechanism by which melatonin causes cancer cells to overcome cytosolic glycolysis, reduce tumor biomass and reverse insensitivity to chemotherapy. Melatonin Res 2(3):105\u2013119. https:\/\/doi.org\/10.32794\/mr11250033","journal-title":"Melatonin Res"},{"key":"4102_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020764","author":"RJ Reiter","year":"2021","unstructured":"Reiter RJ, Sharma R, Rosales-Corral S (2021) Anti-warburg effect of melatonin: a proposed mechanism to explain its inhibition of multiple diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22020764","journal-title":"Int J Mol Sci"},{"key":"4102_CR59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2106017118","author":"T Peng","year":"2021","unstructured":"Peng T, Du SY, Son M, Diamond B (2021) HIF-1alpha is a negative regulator of interferon regulatory factors: implications for interferon production by hypoxic monocytes. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.2106017118","journal-title":"Proc Natl Acad Sci USA"},{"key":"4102_CR60","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2021=0245","author":"S Al-Gburi","year":"2021","unstructured":"Al-Gburi S, Beissert S, Gunther C (2021) Molecular mechanisms of vaculopathy and coagulopathy in COVID-19. Biol Chem. https:\/\/doi.org\/10.1515\/hsz-2021=0245","journal-title":"Biol Chem"},{"issue":"6","key":"4102_CR61","doi-asserted-by":"publisher","first-page":"e046057","DOI":"10.1136\/bmjopen-2020-046057","volume":"11","author":"MA Mansouri","year":"2021","unstructured":"Mansouri MA, Kee F, Garcia L, Bradley DT (2021) Role of systems science in preventing and controlling emerging infectious diseases: protocol for a scoping review. BMJ Open 11(6):e046057. https:\/\/doi.org\/10.1136\/bmjopen-2020-046057","journal-title":"BMJ Open"},{"issue":"6","key":"4102_CR62","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.immuni.2021.04.001","volume":"54","author":"B Zhu","year":"2021","unstructured":"Zhu B, Wu Y, Huang S, Zhang R, Son YM, Li C, Cheon IS, Gao X, Wang M, Chen Y, Zhou X, Nguyen Q, Phan AT, Behl S, Taketo MM, Mack M, Shapiro VS, Zeng H, Ebihara H, Mullon JJ, Edell ES, Reisenauer JS, Demirel N, Kern RM, Chakraborty R, Cui W, Kaplan MH, Zhou X, Goldrath AW, Sun J (2021) Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection. Immunity 54(6):1200-1218e1209. https:\/\/doi.org\/10.1016\/j.immuni.2021.04.001","journal-title":"Immunity"},{"key":"4102_CR63","doi-asserted-by":"publisher","first-page":"104188","DOI":"10.1016\/j.mvr.2021.104188","volume":"137","author":"AH Noroozneezhad","year":"2021","unstructured":"Noroozneezhad AH, Mansouri K (2021) Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19). Microvasc Res 137:104188. https:\/\/doi.org\/10.1016\/j.mvr.2021.104188","journal-title":"Microvasc Res"},{"issue":"3","key":"4102_CR64","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cmet.2020.07.007","volume":"32","author":"AC Codo","year":"2020","unstructured":"Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, Prodonoff JS, Carregari VC, de Biagi Junior CAO, Crunfli F, Jimenez Restrepo JL, Vendramini PH, Reis-de-Oliveira G, Bispo Dos Santos K, Toledo-Teixeira DA, Parise PL, Martini MC, Marques RE, Carmo HR, Borin A, Coimbra LD, Boldrini VO, Brunetti NS, Vieira AS, Mansour E, Ulaf RG, Bernardes AF, Nunes TA, Ribeiro LC, Palma AC, Agrela MV, Moretti ML, Sposito AC, Pereira FB, Velloso LA, Vinolo MAR, Damasio A, Proenca-Modena JL, Carvalho RF, Mori MA, Martins-de-Souza D, Nakaya HI, Farias AS, Moraes-Vieira PM (2020) Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha\/Glycolysis-Dependent Axis. Cell Metab 32(3):437-446e435. https:\/\/doi.org\/10.1016\/j.cmet.2020.07.007","journal-title":"Cell Metab"},{"key":"4102_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18040763","author":"YR Zonta","year":"2017","unstructured":"Zonta YR, Martinez M, Camargo IC, Domeniconi RF, Lupi Junior LA, Pinheiro PF, Reiter RJ, Martinez FE, Chuffa LG (2017) Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18040763","journal-title":"Int J Mol Sci"},{"key":"4102_CR66","doi-asserted-by":"publisher","first-page":"173282","DOI":"10.1016\/j.ejphar.2020.173282","volume":"881","author":"NF Maroufi","year":"2020","unstructured":"Maroufi NF, Amiri M, Dizaji BF, Vahedian V, Akbarzadeh M, Roshanravan N, Haiaty S, Nouri M, Rashidi MR (2020) Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells. Eur J Pharmacol 881:173282. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173282","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"4102_CR67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3892\/ol.2020.12292","volume":"21","author":"W Yin","year":"2021","unstructured":"Yin W, Liu Y, Liu X, Ma X, Sun B, Yu Z (2021) Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR\/HIF-1alpha\/PKM2\/STAT3 pathway. Oncol Lett 21(1):31. https:\/\/doi.org\/10.3892\/ol.2020.12292","journal-title":"Oncol Lett"},{"key":"4102_CR68","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bbcan.2016.02.004","volume":"2","author":"J Vriend","year":"2016","unstructured":"Vriend J, Reiter RJ (2016) Melatonin and the von Hippel-Lindau\/HIF-1 oxygen sensing mechanism: a review. Biochim Biophys Acta 1865 2:176\u2013183. https:\/\/doi.org\/10.1016\/j.bbcan.2016.02.004","journal-title":"Biochim Biophys Acta 1865"},{"key":"4102_CR69","doi-asserted-by":"publisher","first-page":"5406284","DOI":"10.1155\/2020\/5406284","volume":"2020","author":"M He","year":"2020","unstructured":"He M, Zhou C, Lu Y, Mao L, Xi Y, Mei X, Wang X, Zhang L, Yu Z, Zhou Z (2020) Melatonin antagonizes nickel-induced aerobic glycolysis by blocking ROS-mediated HIF-1alpha\/miR210\/ISCU axis activation. Oxid Med Cell Longev 2020:5406284. https:\/\/doi.org\/10.1155\/2020\/5406284","journal-title":"Oxid Med Cell Longev"},{"key":"4102_CR70","doi-asserted-by":"publisher","first-page":"673692","DOI":"10.3389\/fimmu.2021.673692","volume":"12","author":"JH Costa","year":"2021","unstructured":"Costa JH, Mohanapriya G, Bharadwaj R, Noceda C, Thiers KLL, Aziz S, Srivastava S, Oliveira M, Gupta KJ, Kumari A, Sircar D, Kumar SR, Achra A, Sathishkumar R, Adholeya A, Arnholdt-Schmitt B (2021) ROS\/RNS Balancing, Aerobic Fermentation Regulation and Cell Cycle Control\u2014a Complex Early Trait ('CoV-MAC-TED\u2019) for Combating SARS-CoV-2-Induced Cell Reprogramming. Front Immunol 12:673692. https:\/\/doi.org\/10.3389\/fimmu.2021.673692","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"4102_CR71","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1590\/1806-9282.67.Suppl1.20200968","volume":"67","author":"WJ Martorina","year":"2021","unstructured":"Martorina WJ, Tavares A (2021) Possible role of exogenous melatonin in preventing more serious COVID-19 infection in patients with type 2 diabetes mellitus. Rev Assoc Med Bras (1992) 67(Suppl 1):18\u201321. https:\/\/doi.org\/10.1590\/1806-9282.67.Suppl1.20200968","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"4102_CR72","doi-asserted-by":"publisher","first-page":"174193","DOI":"10.1016\/j.ejphar.2021.174193","volume":"904","author":"A Hosseini","year":"2021","unstructured":"Hosseini A, Esmaeili Gouvarchin Ghaleh H, Aghamollaei H, Fasihi Ramandi M, Alishiri G, Shahriary A, Hassanpour K, Tat M, Farnoosh G (2021) Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment. Eur J Pharmacol 904:174193. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174193","journal-title":"Eur J Pharmacol"},{"key":"4102_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-021-01003-x","author":"E Letsiou","year":"2021","unstructured":"Letsiou E, Htwe YM, Dudek SM (2021) Secretory Phospholipase A2 Enzymes in Acute Lung Injury. Cell Biochem Biophys. https:\/\/doi.org\/10.1007\/s12013-021-01003-x","journal-title":"Cell Biochem Biophys"},{"key":"4102_CR74","doi-asserted-by":"publisher","first-page":"100875","DOI":"10.1016\/j.cbd.2021.100875","volume":"40","author":"LP Lee","year":"2021","unstructured":"Lee LP, Tan KY, Tan CH (2021) Snake venom proteomics and antivenomics of two Sundaic lance-headed pit vipers: Trimeresurus wiroti (Malaysia) and Trimeresurus puniceus (Indonesia). Comp Biochem Physiol Part D Genomics Proteomics 40:100875. https:\/\/doi.org\/10.1016\/j.cbd.2021.100875","journal-title":"Comp Biochem Physiol Part D Genomics Proteomics"},{"key":"4102_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13080548","author":"HY Zhao","year":"2021","unstructured":"Zhao HY, Sun Y, Du Y, Li JQ, Lv JG, Qu YF, Lin LH, Lin CX, Ji X, Gao JF (2021) Venom of the annulated sea snake Hydrophis cyanocinctus: a biochemically simple but genetically complex weapon. Toxins (Basel). https:\/\/doi.org\/10.3390\/toxins13080548","journal-title":"Toxins (Basel)"},{"issue":"5","key":"4102_CR76","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/s43440-021-00258-8","volume":"73","author":"H Khan","year":"2021","unstructured":"Khan H, Gupta A, Singh TG, Kaur A (2021) Mechanistic insight on the role of leukotriene receptors in ischemic-reperfusion injury. Pharmacol Rep 73(5):1240\u20131254. https:\/\/doi.org\/10.1007\/s43440-021-00258-8","journal-title":"Pharmacol Rep"},{"issue":"5","key":"4102_CR77","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3390\/biom11050717","volume":"11","author":"A Kulkarni","year":"2021","unstructured":"Kulkarni A, Nadler JL, Mirmira R, Casimiuro I (2021) Regulation of tissue inflammation by 12-lipoxygenase. Biomolcules 11(5):717. https:\/\/doi.org\/10.3390\/biom11050717","journal-title":"Biomolcules"},{"key":"4102_CR78","doi-asserted-by":"publisher","first-page":"106482","DOI":"10.1016\/j.prostaglandins.2020.106482","volume":"152","author":"A Trostchansky","year":"2021","unstructured":"Trostchansky A, Wood I, Rubbo H (2021) Regulation of arachidonic acid oxidation and metabolism by lipid electrophiles. Prostaglandins Other Lipid Mediat 152:106482. https:\/\/doi.org\/10.1016\/j.prostaglandins.2020.106482","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"4102_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158295","author":"MG Appiah","year":"2021","unstructured":"Appiah MG, Park EJ, Akama Y, Nakamori Y, Kawamoto E, Gaowa A, Shimaoka M (2021) Cellular and exosomal regulations of sepsis-induced metabolic alterations. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22158295","journal-title":"Int J Mol Sci"},{"key":"4102_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/biology9090249","author":"G Anderson","year":"2020","unstructured":"Anderson G, Carbone A, Mazzoccoli G (2020) Aryl Hydrocarbon Receptor Role in Co-Ordinating SARS-CoV-2 Entry and Symptomatology: Linking Cytotoxicity Changes in COVID-19 and Cancers; Modulation by Racial Discrimination Stress. Biology (Basel). https:\/\/doi.org\/10.3390\/biology9090249","journal-title":"Biology (Basel)"},{"key":"4102_CR81","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jcrc.2017.09.012","volume":"43","author":"D Bar-Or","year":"2018","unstructured":"Bar-Or D, Carrick M, Tanner A 2nd, Lieser MJ, Rael LT, Brody E (2018) Overcoming the Warburg Effect: Is it the key to survival in sepsis? J Crit Care 43:197\u2013201. https:\/\/doi.org\/10.1016\/j.jcrc.2017.09.012","journal-title":"J Crit Care"},{"key":"4102_CR82","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12755","author":"X Chen","year":"2021","unstructured":"Chen X, Hao B, Li D, Reiter RJ, Bai Y, Abay B, Chen G, Lin S, Zheng T, Ren Y, Xu X, Li M, Fan L (2021) Melatonin inhibits lung cancer development by reversing the Warburg effect via stimulating the SIRT3\/PDH axis. J Pineal Res. https:\/\/doi.org\/10.1111\/jpi.12755","journal-title":"J Pineal Res"},{"issue":"1","key":"4102_CR83","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41392-021-00745-7","volume":"6","author":"M Li","year":"2021","unstructured":"Li M, Hao B, Zhang M, Reiter RJ, Lin S, Zheng T, Chen X, Ren Y, Yue L, Abay B, Chen G, Xu X, Shi Y, Fan L (2021) Melatonin enhances radiofrequency-induced NK antitumor immunity, causing cancer metabolism reprogramming and inhibition of multiple pulmonary tumor development. Signal Transduct Target Ther 6(1):330. https:\/\/doi.org\/10.1038\/s41392-021-00745-7","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"4102_CR84","doi-asserted-by":"publisher","first-page":"e0180554","DOI":"10.1371\/journal.pone.0180554","volume":"12","author":"TL Tan","year":"2017","unstructured":"Tan TL, Goh YY (2017) The role of group IIA secretory phospholipase A2 (sPLA2- IIA) as a biomarker for the diagnosis of sepsis and bacterial infection in adults-A systematic review. PLoS ONE 12(7):e0180554. https:\/\/doi.org\/10.1371\/journal.pone.0180554","journal-title":"PLoS ONE"},{"key":"4102_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12020068","author":"PE Bickler","year":"2020","unstructured":"Bickler PE (2020) Amplification of Snake Venom Toxicity by Endogenous Signaling Pathways. Toxins (Basel). https:\/\/doi.org\/10.3390\/toxins12020068","journal-title":"Toxins (Basel)"},{"issue":"1","key":"4102_CR86","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1038\/s41598-019-40903-0","volume":"9","author":"PL de Araujo","year":"2019","unstructured":"de Araujo PL, de Almeida MES, Bretones ML, Cirillo MC, Curi R, Sampaio SC (2019) Crotoxin promotes macrophage reprogramming towards an antiangiogenic phenotype. Sci Rep 9(1):4281. https:\/\/doi.org\/10.1038\/s41598-019-40903-0","journal-title":"Sci Rep"},{"issue":"3","key":"4102_CR87","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/jpi.12123","volume":"56","author":"GD Katkar","year":"2014","unstructured":"Katkar GD, Sundaram MS, Hemshekhar M, Sharma DR, Santhosh MS, Sunitha K, Rangappa KS, Girish KS, Kemparaju K (2014) Melatonin alleviates Echis carinatus venom-induced toxicities by modulating inflammatory mediators and oxidative stress. J Pineal Res 56(3):295\u2013312. https:\/\/doi.org\/10.1111\/jpi.12123","journal-title":"J Pineal Res"},{"key":"4102_CR88","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.actatropica.2014.12.007","volume":"143","author":"AE Abdel Moneim","year":"2015","unstructured":"Abdel Moneim AE, Ortiz F, Leonardo-Mendonca RC, Vergano-Villodres R, Guerrero-Martinez JA, Lopez LC, Acuna-Castroviejo D, Escames G (2015) Protective effects of melatonin against oxidative damage induced by Egyptian cobra (Naja haje) crude venom in rats. Acta Trop 143:58\u201365. https:\/\/doi.org\/10.1016\/j.actatropica.2014.12.007","journal-title":"Acta Trop"},{"key":"4102_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115555","author":"M Estaras","year":"2021","unstructured":"Estaras M, Gonzalez-Portillo MR, Fernandez-Bermejo M, Mateos JM, Vara D, Blanco-Fernandez G, Lopez-Guerra D, Roncero V, Salido GM, Gonzalez A (2021) Melatonin Induces Apoptosis and Modulates Cyclin Expression and MAPK Phosphorylation in Pancreatic Stellate Cells Subjected to Hypoxia. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22115555","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4102_CR90","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1600-079X.2009.00688.x","volume":"47","author":"A Marino","year":"2009","unstructured":"Marino A, Di Paola R, Crisafulli C, Mazzon E, Morabito R, Paterniti I, Galuppo M, Genovese T, La Spada G, Cuzzocrea S (2009) Protective effect of melatonin against the inflammatory response elicited by crude venom from isolated nematocysts of Pelagia noctiluca (Cnidaria, Scyphozoa). J Pineal Res 47(1):56\u201369. https:\/\/doi.org\/10.1111\/j.1600-079X.2009.00688.x","journal-title":"J Pineal Res"},{"issue":"3","key":"4102_CR91","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/jpi.12360","volume":"61","author":"RJ Reiter","year":"2016","unstructured":"Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M, Qin L (2016) Melatonin as an antioxidant: under promises but over delivers. J Pineal Res 61(3):253\u2013278. https:\/\/doi.org\/10.1111\/jpi.12360","journal-title":"J Pineal Res"},{"key":"4102_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051223","author":"R Hardeland","year":"2019","unstructured":"Hardeland R (2019) Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20051223","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4102_CR93","doi-asserted-by":"publisher","first-page":"e12539","DOI":"10.1111\/jpi.12539","volume":"66","author":"A Perez-Gonzalez","year":"2019","unstructured":"Perez-Gonzalez A, Castaneda-Arriaga R, Alvarez-Idaboy JR, Reiter RJ, Galano A (2019) Melatonin and its metabolites as chemical agents capable of directly repairing oxidized DNA. J Pineal Res 66(2):e12539. https:\/\/doi.org\/10.1111\/jpi.12539","journal-title":"J Pineal Res"},{"key":"4102_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25194410","author":"DX Tan","year":"2020","unstructured":"Tan DX, Hardeland R (2020) Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19. Molecules. https:\/\/doi.org\/10.3390\/molecules25194410","journal-title":"Molecules"},{"key":"4102_CR95","doi-asserted-by":"publisher","unstructured":"Castillo RR, Quizon GRA, Juco MJM, Roman ADE, de Leon DG, Punzalan FER, R.B.L. G, Morales DD, Tan D-X, Reiter RJ (2020) Melatonin as adjuvant treatment for coronavirus disease 2019 pneumonia patients requiring hospitalization (MAC-19 PRO): a case series. Melatonin Res 3 (3):297-310. https:\/\/doi.org\/10.32794\/mr11250063","DOI":"10.32794\/mr11250063"},{"key":"4102_CR96","doi-asserted-by":"publisher","unstructured":"Farnoosh G, Akbariqomi M, Badri T, Bagheri M, Izadi M, Saeedi-Boroujeni A, Rezaie E, Ghaleh HEG, Aghamollaei H, Fasihi-Ramandi M, Hassanpour K, Alishiri G (2021) Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial. Arch Med Res. https:\/\/doi.org\/10.1016\/j.arcmed.2021.06.006","DOI":"10.1016\/j.arcmed.2021.06.006"},{"issue":"4","key":"4102_CR97","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1600-079x.1996.tb00288.x","volume":"21","author":"LC Ellis","year":"1996","unstructured":"Ellis LC (1996) Melatonin reduces mortality from Aleutian disease in mink (Mustela vison). J Pineal Res 21(4):214\u2013217. https:\/\/doi.org\/10.1111\/j.1600-079x.1996.tb00288.x","journal-title":"J Pineal Res"},{"key":"4102_CR98","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-1-4615-4709-9_28","volume":"467","author":"GJ Maestroni","year":"1999","unstructured":"Maestroni GJ (1999) Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer. Adv Exp Med Biol 467:217\u2013226. https:\/\/doi.org\/10.1007\/978-1-4615-4709-9_28","journal-title":"Adv Exp Med Biol"},{"key":"4102_CR99","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.actatropica.2014.04.021","volume":"137","author":"JR Vielma","year":"2014","unstructured":"Vielma JR, Bonilla E, Chacin-Bonilla L, Mora M, Medina-Leendertz S, Bravo Y (2014) Effects of melatonin on oxidative stress, and resistance to bacterial, parasitic, and viral infections: a review. Acta Trop 137:31\u201338. https:\/\/doi.org\/10.1016\/j.actatropica.2014.04.021","journal-title":"Acta Trop"},{"issue":"3\u20134","key":"4102_CR100","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/2040206616660851","volume":"24","author":"M Montiel","year":"2015","unstructured":"Montiel M, Bonilla E, Valero N, Mosquera J, Espina LM, Quiroz Y, Alvarez-Mon M (2015) Melatonin decreases brain apoptosis, oxidative stress, and CD200 expression and increased survival rate in mice infected by Venezuelan equine encephalitis virus. Antivir Chem Chemother 24(3\u20134):99\u2013108. https:\/\/doi.org\/10.1177\/2040206616660851","journal-title":"Antivir Chem Chemother"},{"key":"4102_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/v13040659","author":"A Morchang","year":"2021","unstructured":"Morchang A, Malakar S, Poonudom K, Noisakran S, Yenchitsomanus PT, Limjindaporn T (2021) Melatonin Inhibits Dengue Virus Infection via the Sirtuin 1-Mediated Interferon Pathway. Viruses. https:\/\/doi.org\/10.3390\/v13040659","journal-title":"Viruses"},{"key":"4102_CR102","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12754","author":"X Zhai","year":"2021","unstructured":"Zhai X, Wang N, Jiao H, Zhang J, Li C, Ren W, Reiter RJ, Su S (2021) Melatonin and other indoles show antiviral activities against swine coronaviruses in vitro at pharmacological concentrations. J Pineal Res. https:\/\/doi.org\/10.1111\/jpi.12754","journal-title":"J Pineal Res"},{"key":"4102_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.10.012","author":"ZT Hasan","year":"2021","unstructured":"Hasan ZT, Atrakji D, Mehuaiden DAK (2021) The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients. Int J Infect Dis. https:\/\/doi.org\/10.1016\/j.ijid.2021.10.012","journal-title":"Int J Infect Dis"},{"issue":"1","key":"4102_CR104","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/jmv.27312","volume":"94","author":"SA Mousavi","year":"2022","unstructured":"Mousavi SA, Heydari K, Mehravaran H, Saeedi M, Alizadeh-Navaei R, Hedayatizadeh-Omran A, Shamshirian A (2022) Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, randomized, controlled trial. J Med Virol 94(1):263\u2013271. https:\/\/doi.org\/10.1002\/jmv.27312","journal-title":"J Med Virol"},{"issue":"4","key":"4102_CR105","first-page":"494","volume":"20","author":"Z Alizadeh","year":"2021","unstructured":"Alizadeh Z, Keyhanian N, Ghaderkhani S, Dashti-Khavidaki S, Shokouhi Shoormasti R, Pourpak Z (2021) A Pilot Study on Controlling Coronavirus Disease 2019 (COVID-19) Inflammation Using Melatonin Supplement. Iran J Allergy Asthma Immunol 20(4):494\u2013499","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"4","key":"4102_CR106","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1600-079x.1986.tb00760.x","volume":"3","author":"RL Sack","year":"1986","unstructured":"Sack RL, Lewy AJ, Erb DL, Vollmer WM, Singer CM (1986) Human melatonin production decreases with age. J Pineal Res 3(4):379\u2013388. https:\/\/doi.org\/10.1111\/j.1600-079x.1986.tb00760.x","journal-title":"J Pineal Res"},{"key":"4102_CR107","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jpsychores.2016.05.005","volume":"86","author":"RM Scholtens","year":"2016","unstructured":"Scholtens RM, van Munster BC, van Kempen MF, de Rooij SE (2016) Physiological melatonin levels in healthy older people: a systematic review. J Psychosom Res 86:20\u201327. https:\/\/doi.org\/10.1016\/j.jpsychores.2016.05.005","journal-title":"J Psychosom Res"},{"issue":"1","key":"4102_CR108","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12871-021-01511-6","volume":"21","author":"S Oba","year":"2021","unstructured":"Oba S, Altinay M, Salkaya A, Turk HS (2021) Evaluation of the effect of clinical characteristics and intensive care treatment methods on the mortality of covid-19 patients aged 80 years and older. BMC Anesthesiol 21(1):291. https:\/\/doi.org\/10.1186\/s12871-021-01511-6","journal-title":"BMC Anesthesiol"},{"key":"4102_CR109","first-page":"199","volume":"21","author":"GM Vaughan","year":"1986","unstructured":"Vaughan GM (1986) Human melatonin in physiologic and diseased states: neural control of the rhythm. J Neural Transm Suppl 21:199\u2013215","journal-title":"J Neural Transm Suppl"},{"issue":"4","key":"4102_CR110","doi-asserted-by":"publisher","first-page":"558","DOI":"10.32794\/mr11250079","volume":"3","author":"S Pandi-Perumal","year":"2020","unstructured":"Pandi-Perumal S, Cardinali D, Reiter RJ, Brown G (2020) Low melatonin as a contributor to SARS-CoV-2 disease. Melatonin Res 3(4):558\u2013576. https:\/\/doi.org\/10.32794\/mr11250079","journal-title":"Melatonin Res"},{"issue":"4","key":"4102_CR111","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1210\/jcem-45-4-768","volume":"45","author":"JJ Nordlund","year":"1977","unstructured":"Nordlund JJ, Lerner AB (1977) The effects of oral melatonin on skin color and on the release of pituitary hormones. J Clin Endocrinol Metab 45(4):768\u2013774. https:\/\/doi.org\/10.1210\/jcem-45-4-768","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4102_CR112","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12762","volume":"71","author":"KH Lu","year":"2021","unstructured":"Lu KH, Lu PW, Lu EW, Tang CH, Su SC, Lin CW, Yang SF (2021) The potential remedy of melatonin on osteoarthritis. J Pineal Res 71(3):e12762. https:\/\/doi.org\/10.1111\/jpi.12762","journal-title":"J Pineal Res"},{"key":"4102_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10081179","author":"AK Jaworek","year":"2021","unstructured":"Jaworek AK, Szepietowski JC, Halubiec P, Wojas-Pelc A, Jaworek J (2021) Melatonin as an antioxidant and immunomodulator in atopic dermatitis-a new look on an old story: a review. Antioxidants. https:\/\/doi.org\/10.3390\/antiox10081179","journal-title":"Antioxidants"},{"key":"4102_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158296","author":"R Hardeland","year":"2021","unstructured":"Hardeland R (2021) Melatonin and Microglia. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22158296","journal-title":"Int J Mol Sci"},{"key":"4102_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10010047","author":"P Wongchitrat","year":"2021","unstructured":"Wongchitrat P, Shukla M, Sharma R, Govitrapong P, Reiter RJ (2021) Role of Melatonin on Virus-Induced Neuropathogenesis-A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox10010047","journal-title":"Antioxidants (Basel)"},{"issue":"21","key":"4102_CR116","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1007\/s00018-017-2613-y","volume":"74","author":"OC Baltatu","year":"2017","unstructured":"Baltatu OC, Amaral FG, Campos LA, Cipolla-Neto J (2017) Melatonin, mitochondria and hypertension. Cell Mol Life Sci 74(21):3955\u20133964. https:\/\/doi.org\/10.1007\/s00018-017-2613-y","journal-title":"Cell Mol Life Sci"},{"key":"4102_CR117","doi-asserted-by":"publisher","first-page":"e20200183","DOI":"10.1590\/1678-9199-JVATITD-2020-0183","volume":"27","author":"VP Targhetta","year":"2021","unstructured":"Targhetta VP, Amaral MA, Camara NOS (2021) Through DNA sensors and hidden mitochondrial effects of SARS-CoV-2. J Venom Anim Toxins Incl Trop Dis 27:e20200183. https:\/\/doi.org\/10.1590\/1678-9199-JVATITD-2020-0183","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"issue":"1","key":"4102_CR118","doi-asserted-by":"publisher","first-page":"20476","DOI":"10.1038\/s41598-021-00064-5","volume":"11","author":"B Alonazi","year":"2021","unstructured":"Alonazi B, Farghaly AM, Mostafa MA, Al-Watban JA, Zindani SA, Altaimi F, Fagiry MA, Mahmoud MZ (2021) Brain MRI in SARS-CoV-2 pneumonia patients with newly developed neurological manifestations suggestive of brain involvement. Sci Rep 11(1):20476. https:\/\/doi.org\/10.1038\/s41598-021-00064-5","journal-title":"Sci Rep"},{"issue":"34","key":"4102_CR119","doi-asserted-by":"publisher","first-page":"5682","DOI":"10.3748\/wjg.v27.i34.5682","volume":"27","author":"D Ristic-Medic","year":"2021","unstructured":"Ristic-Medic D, Petrovic S, Arsic A, Vucic V (2021) Liver disease and COVID-19: the link with oxidative stress, antioxidants and nutrition. World J Gastroenterol 27(34):5682\u20135699. https:\/\/doi.org\/10.3748\/wjg.v27.i34.5682","journal-title":"World J Gastroenterol"},{"issue":"7","key":"4102_CR120","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.14336\/AD.2021.0709","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Wang Z, Cao W, Wu Q, Yuan Y, Zhang X (2021) Regulatory T cells in COVID-19. Aging Dis 12(7):1545\u20131553. https:\/\/doi.org\/10.14336\/AD.2021.0709","journal-title":"Aging Dis"},{"key":"4102_CR121","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bcp.2019.03.008","volume":"165","author":"C Vaamonde-Garcia","year":"2019","unstructured":"Vaamonde-Garcia C, Lopez-Armada MJ (2019) Role of mitochondrial dysfunction on rheumatic diseases. Biochem Pharmacol 165:181\u2013195. https:\/\/doi.org\/10.1016\/j.bcp.2019.03.008","journal-title":"Biochem Pharmacol"},{"key":"4102_CR122","doi-asserted-by":"publisher","first-page":"734388","DOI":"10.3389\/fcvm.2021.734388","volume":"8","author":"X Xu","year":"2021","unstructured":"Xu X, Lin JI, Bais AS, Reynolds MJ, Tan T, Gabriel GC, Kondos Z, Liu X, Shiva SS, Lo CW (2021) Mitochondrial respiration defects in single-ventricle congenital heart disease. Front Cardiovasc Med 8:734388. https:\/\/doi.org\/10.3389\/fcvm.2021.734388","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"4102_CR123","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41420-021-00675-x","volume":"7","author":"Q Yang","year":"2021","unstructured":"Yang Q, Wang L, Liu J, Cao W, Pan Q, Li M (2021) Targeting the complex I and III of mitochondrial electron transport chain as a potentially viable option in liver cancer management. Cell Death Discovery 7(1):293. https:\/\/doi.org\/10.1038\/s41420-021-00675-x","journal-title":"Cell Death Discovery"},{"key":"4102_CR124","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12774","author":"C Chen","year":"2021","unstructured":"Chen C, Yang C, Wang J, Huang X, Yu H, Li S, Li S, Zhang Z, Liu J, Yang X, Liu GP (2021) Melatonin ameliorates cognitive deficits through improving mitophagy in a mouse model of Alzheimer\u2019s disease. J Pineal Res. https:\/\/doi.org\/10.1111\/jpi.12774","journal-title":"J Pineal Res"},{"key":"4102_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22157979","author":"L Rochette","year":"2021","unstructured":"Rochette L, Ghibu S (2021) Mechanics insights of alpha-lipoic acid against cardiovascular diseases during COVID-19 infection. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22157979","journal-title":"Int J Mol Sci"},{"issue":"25","key":"4102_CR126","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1523\/JNEUROSCI.3188-20.2021","volume":"41","author":"O Swain","year":"2021","unstructured":"Swain O, Romano SK, Miryala R, Tsai J, Parikh V, Umanah GKE (2021) SARS-CoV-2 neuronal invasion and complications: potential mechanisms and therapeutic approaches. J Neurosci 41(25):5338\u20135349. https:\/\/doi.org\/10.1523\/JNEUROSCI.3188-20.2021","journal-title":"J Neurosci"},{"issue":"4","key":"4102_CR127","doi-asserted-by":"publisher","first-page":"E929","DOI":"10.9778\/cmajo.20210044","volume":"9","author":"M Science","year":"2021","unstructured":"Science M, Bolotin S, Silverman M, Nadarajah J, Maguire B, Parekh RS, McGeer A, Schwartz KL, Alexander L, Allen U, Ariyarajah A, Castellani L, Cohn RD, Downing M, Katz K, Kazmi K, Leis JA, Liu D, Pernica JM, Schneiderman JE, Sumaida M, Campigotto A (2021) SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort study. CMAJ Open 9(4):E929\u2013E939. https:\/\/doi.org\/10.9778\/cmajo.20210044","journal-title":"CMAJ Open"},{"issue":"4","key":"4102_CR128","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1600-079X.2012.01002.x","volume":"53","author":"MZ Xia","year":"2012","unstructured":"Xia MZ, Liang YL, Wang H, Chen X, Huang YY, Zhang ZH, Chen YH, Zhang C, Zhao M, Xu DX, Song LH (2012) Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW2647 cells. J Pineal Res 53(4):325\u2013334. https:\/\/doi.org\/10.1111\/j.1600-079X.2012.01002.x","journal-title":"J Pineal Res"},{"issue":"13","key":"4102_CR129","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00018-019-03438-1","volume":"77","author":"RJ Reiter","year":"2020","unstructured":"Reiter RJ, Sharma R, Ma Q, Rorsales-Corral S, de Almeida Chuffa LG (2020) Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis. Cell Mol Life Sci 77(13):2527\u20132542. https:\/\/doi.org\/10.1007\/s00018-019-03438-1","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"4102_CR130","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1152\/physiol.00034.2019","volume":"35","author":"RJ Reiter","year":"2020","unstructured":"Reiter RJ, Ma Q, Sharma R (2020) Melatonin in mitochondria: mitigating clear and present dangers. Physiology (Bethesda) 35(2):86\u201395. https:\/\/doi.org\/10.1152\/physiol.00034.2019","journal-title":"Physiology (Bethesda)"},{"issue":"38","key":"4102_CR131","doi-asserted-by":"publisher","first-page":"E7997","DOI":"10.1073\/pnas.1705768114","volume":"114","author":"Y Suofu","year":"2017","unstructured":"Suofu Y, Li W, Jean-Alphonse FG, Jia J, Khattar NK, Li J, Baranov SV, Leronni D, Mihalik AC, He Y, Cecon E, Wehbi VL, Kim J, Heath BE, Baranova OV, Wang X, Gable MJ, Kretz ES, Di Benedetto G, Lezon TR, Ferrando LM, Larkin TM, Sullivan M, Yablonska S, Wang J, Minnigh MB, Guillaumet G, Suzenet F, Richardson RM, Poloyac SM, Stolz DB, Jockers R, Witt-Enderby PA, Carlisle DL, Vilardaga JP, Friedlander RM (2017) Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release. Proc Natl Acad Sci USA 114(38):E7997\u2013E8006. https:\/\/doi.org\/10.1073\/pnas.1705768114","journal-title":"Proc Natl Acad Sci USA"},{"key":"4102_CR132","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.2147\/JIR.S323356","volume":"14","author":"RD Castle","year":"2021","unstructured":"Castle RD, Williams MA, Bushell WC, Rindfleisch JA, Peterson CT, Marzolf J, Brouwer K, Mills PJ (2021) Implications for systemic approaches to COVID-19: effect sizes of remdesivir, tocilizumab, melatonin, vitamin D3, and meditation. J Inflamm Res 14:4859\u20134876. https:\/\/doi.org\/10.2147\/JIR.S323356","journal-title":"J Inflamm Res"},{"key":"4102_CR133","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41525-020-00143-y","volume":"5","author":"T Takahashi","year":"2020","unstructured":"Takahashi T, Luzum JA, Nicol MR, Jacobson PA (2020) Pharmacogenomics of COVID-19 therapies. NPJ Genom Med 5:35. https:\/\/doi.org\/10.1038\/s41525-020-00143-y","journal-title":"NPJ Genom Med"},{"issue":"1","key":"4102_CR134","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jmii.2020.09.002","volume":"54","author":"CJ Yang","year":"2021","unstructured":"Yang CJ, Wei YJ, Chang HL, Chang PY, Tsai CC, Chen YH, Hsueh PR (2021) Remdesivir use in the coronavirus disease 2019 pandemic: a mini-review. J Microbiol Immunol Infect 54(1):27\u201336. https:\/\/doi.org\/10.1016\/j.jmii.2020.09.002","journal-title":"J Microbiol Immunol Infect"},{"key":"4102_CR135","doi-asserted-by":"publisher","first-page":"h4826","DOI":"10.1136\/bmj.h4826","volume":"351","author":"TS Anderson","year":"2015","unstructured":"Anderson TS, Good CB, Gellad WF (2015) Prevalence and compensation of academic leaders, professors, and trustees on publicly traded US healthcare company boards of directors: cross sectional study. BMJ 351:h4826. https:\/\/doi.org\/10.1136\/bmj.h4826","journal-title":"BMJ"},{"issue":"18","key":"4102_CR136","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1001\/jama.2020.21021","volume":"324","author":"C Becker","year":"2020","unstructured":"Becker C (2020) Relationships between academic medicine leaders and industry-time for another look? JAMA 324(18):1833\u20131834. https:\/\/doi.org\/10.1001\/jama.2020.21021","journal-title":"JAMA"},{"key":"4102_CR137","doi-asserted-by":"publisher","first-page":"n16","DOI":"10.1136\/bmj.n16","volume":"372","author":"O Dyer","year":"2021","unstructured":"Dyer O (2021) Covid-19: \u201cShkreli Awards\u201d go to pandemic\u2019s top profiteers. BMJ 372:n16. https:\/\/doi.org\/10.1136\/bmj.n16","journal-title":"BMJ"},{"key":"4102_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092561","author":"K Kleszczynski","year":"2020","unstructured":"Kleszczynski K, Slominski AT, Steinbrink K, Reiter RJ (2020) Clinical Trials for Use of Melatonin to Fight against COVID-19 Are Urgently Needed. Nutrients. https:\/\/doi.org\/10.3390\/nu12092561","journal-title":"Nutrients"},{"issue":"8","key":"4102_CR139","doi-asserted-by":"publisher","first-page":"e2122255","DOI":"10.1001\/jamanetworkopen.2021.22255","volume":"4","author":"R Shavit","year":"2021","unstructured":"Shavit R, Maoz-Segal R, Iancovici-Kidon M, Offengenden I, Haj Yahia S, Machnes Maayan D, Lifshitz-Tunitsky Y, Niznik S, Frizinsky S, Deutch M, Elbaz E, Genaim H, Rahav G, Levy I, Belkin A, Regev-Yochay G, Afek A, Agmon-Levin N (2021) Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk. JAMA Netw Open 4(8):e2122255. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.22255","journal-title":"JAMA Netw Open"},{"issue":"9","key":"4102_CR140","doi-asserted-by":"publisher","first-page":"e2125524","DOI":"10.1001\/jamanetworkopen.2021.25524","volume":"4","author":"CM Warren","year":"2021","unstructured":"Warren CM, Snow TT, Lee AS, Shah MM, Heider A, Blomkalns A, Betts B, Buzzanco AS, Gonzalez J, Chinthrajah RS, Do E, Chang I, Dunham D, Lee G, O\u2019Hara R, Park H, Shamji MH, Schilling L, Sindher SB, Sisodiya D, Smith E, Tsai M, Galli SJ, Akdis C, Nadeau KC (2021) Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. JAMA Netw Open 4(9):e2125524. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.25524","journal-title":"JAMA Netw Open"},{"key":"4102_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2021.08.024","author":"BH Bardenheier","year":"2021","unstructured":"Bardenheier BH, Gravenstein S, Blackman C, Gutman R, Sarkar IN, Feifer RA, White EM, McConeghy K, Nanda A, Bosco E, Mor V (2021) Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection. J Am Med Dir Assoc. https:\/\/doi.org\/10.1016\/j.jamda.2021.08.024","journal-title":"J Am Med Dir Assoc"},{"key":"4102_CR142","doi-asserted-by":"publisher","first-page":"711605","DOI":"10.3389\/fnins.2021.711605","volume":"15","author":"RU Lee","year":"2021","unstructured":"Lee RU, Glickman GL (2021) Sleep, Circadian Health and Melatonin for Mitigating COVID-19 and Optimizing Vaccine Efficacy. Front Neurosci 15:711605. https:\/\/doi.org\/10.3389\/fnins.2021.711605","journal-title":"Front Neurosci"},{"issue":"1","key":"4102_CR143","doi-asserted-by":"publisher","first-page":"30","DOI":"10.32794\/mr11250081","volume":"4","author":"S Gurunathan","year":"2021","unstructured":"Gurunathan S, Kang M-H, Choi Y, Reiter RJ, Kim J-H (2021) Melatonin: a potential therapeutic agent against COVID-19. Melatonin Res 4(1):30\u201369. https:\/\/doi.org\/10.32794\/mr11250081","journal-title":"Melatonin Res"},{"key":"4102_CR144","doi-asserted-by":"publisher","unstructured":"Cardinali DP, Brown GM, Pandi-Perumal SR An urgent proposal for the immediate use of melatonin as an adjuvant to anti- SARS-CoV-2 vaccination. Melatonin Res 4 (1):206\u2013212. doi:https:\/\/doi.org\/10.32794\/mr11250091.","DOI":"10.32794\/mr11250091"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-04102-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-021-04102-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-04102-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T07:12:22Z","timestamp":1650957142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-021-04102-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,20]]},"references-count":144,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["4102"],"URL":"https:\/\/doi.org\/10.1007\/s00018-021-04102-3","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,20]]},"assertion":[{"value":"19 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"143"}}